Cellectis Adr (CLLS)

May 21, 2025

Cellectis S.A. announces board change and meeting By Investing.com - Investing.com India

May 21, 2025

May 21, 2025

Cellectis S.A. announces board change and meeting - Investing.com

May 21, 2025

May 15, 2025

European Equities See Growth In US Trade - Finimize

May 15, 2025

May 12, 2025

Cellectis earnings beat by $0.06, revenue topped estimates - Investing.com India

May 12, 2025

May 12, 2025

Cellectis earnings beat by $0.07, revenue topped estimates - Investing.com

May 12, 2025

Apr 22, 2025

Cellectis Charts Course For 2025 With Boost From AstraZeneca Deal - Barchart.com

Apr 22, 2025

Apr 11, 2025

European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading - TradingView

Apr 11, 2025

Apr 08, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - TradingView

Apr 08, 2025

Apr 04, 2025

Cellectis stock touches 52-week low at $1.14 amid market challenges - Investing.com

Apr 04, 2025

Apr 02, 2025

European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading - TradingView

Apr 02, 2025

Mar 20, 2025

European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading - TradingView

Mar 20, 2025

Mar 18, 2025

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - TradingView

Mar 18, 2025

Mar 17, 2025

European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading - TradingView

Mar 17, 2025

Mar 17, 2025

Cellectis’s SWOT analysis: biotech firm’s stock faces CAR T challenges - Investing.com

Mar 17, 2025

Mar 15, 2025

Earnings call transcript: Cellectis beats Q4 2024 expectations, stock up 10% By Investing.com - Investing.com South Africa

Mar 15, 2025

Mar 14, 2025

Cellectis stock touches 52-week low at $1.2 amid market challenges - Investing.com India

Mar 14, 2025

Mar 14, 2025

Earnings call transcript: Cellectis beats Q4 2024 expectations, stock up 10% - Investing.com India

Mar 14, 2025

Mar 14, 2025

What Recent Market Trends Mean for Cosan S.A ADR’s (CSAN) Stock - The News Heater

Mar 14, 2025

Mar 11, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - TradingView

Mar 11, 2025

Mar 07, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up Slightly for Week - TradingView

Mar 07, 2025

Mar 06, 2025

Cellectis stock touches 52-week low at $1.24 amid market challenges - Investing.com India

Mar 06, 2025

Mar 06, 2025

European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading - TradingView

Mar 06, 2025

Feb 28, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week - TradingView

Feb 28, 2025

Feb 27, 2025

StockNews.com Begins Coverage on Cellectis (NASDAQ:CLLS) - MarketBeat

Feb 27, 2025

Feb 27, 2025

Cellectis earnings missed by $0.20, revenue fell short of estimates - Investing.com

Feb 27, 2025

Feb 25, 2025

Cellectis stock touches 52-week low at $1.4 amid market challenges By Investing.com - Investing.com South Africa

Feb 25, 2025

Feb 25, 2025

Cellectis stock touches 52-week low at $1.4 amid market challenges - Investing.com India

Feb 25, 2025

Feb 24, 2025

Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025 - GlobeNewswire Inc.

Feb 24, 2025

Feb 14, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Up 1% for Week - TradingView

Feb 14, 2025

Feb 07, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, End Week Up 3.2% - TradingView

Feb 07, 2025

Jan 03, 2025

This Penny Stock Has 270% Upside Potential In 2025. Is It A Buy Now? - Barchart

Jan 03, 2025

Dec 29, 2024

Analysts Predict 400% Upside Potential for This Penny Stock - Yahoo Finance

Dec 29, 2024

Dec 26, 2024

Cellectis stock plunges to 52-week low at $1.52 amid market challenges - Investing.com India

Dec 26, 2024

Dec 16, 2024

Cellectis stock touches 52-week low at $1.7 amid market challenges - Investing.com

Dec 16, 2024

Dec 15, 2024

Cellectis's SWOT analysis: CAR T pioneer's stock faces pivotal year - Investing.com India

Dec 15, 2024

Nov 25, 2024

Cellectis's SWOT analysis: CAR T pioneer's stock faces pivotal year ahead - Investing.com

Nov 25, 2024

Nov 06, 2024

Cellectis stock touches 52-week low at $1.75 amid market challenges - Investing.com

Nov 06, 2024

Nov 05, 2024

Baird maintains $10 target on Cellectis amid strong AZN partnership - Investing.com

Nov 05, 2024

May 06, 2024

AstraZeneca completes equity investment agreement with Cellectis - AstraZeneca

May 06, 2024

Aug 01, 2023

CellectisADR (CLLS) Price Target Increased by 7.35% to 11.62 - Nasdaq

Aug 01, 2023

Jun 30, 2022

Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing - Nature

Jun 30, 2022

Feb 26, 2021

Biotech Stocks Rise After FDA Halts Test By Rival Blood Cancer Firm Cellectis - Investor's Business Daily

Feb 26, 2021

Feb 21, 2021

Current Cathie Wood Portfolio 2021: Ark Invest Holdings - New Trader U

Feb 21, 2021

Dec 28, 2020

Current Cathie Wood Portfolio 2020: Ark Invest Holdings - New Trader U

Dec 28, 2020

Oct 18, 2017

7 Gene Editing Companies Investors Should Watch - Nanalyze

Oct 18, 2017

Jul 21, 2017

AZN Stock Price and Chart — LSE:AZN - TradingView

Jul 21, 2017